FC
BIIB icon

Ferris Capital’s Biogen BIIB Stock Holding History

Ferris Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-858
Closed -$210K – 188
2020
Q4 		$210K Sell
858
-12
-1% -$3.1K 0.06% 176
2020
Q3 		$247K Buy
870
+3
+0.3% +$837 0.08% 150
2020
Q2 		$232K Buy
867
+9
+1% +$2.71K 0.08% 152
2020
Q1 		$271K Sell
858
-16
-2% -$4.86K 0.12% 125
2019
Q4 		$259K Buy
+874
New +$243K 0.09% 141
2019
Q2 		– Sell
-688
Closed -$163K – 220
2019
Q1 		$163K Buy
688
+200
+41% +$63K 0.06% 173
2018
Q4 		$147K Sell
488
-27
-5% -$8.62K 0.07% 173
2018
Q3 		$182K Sell
515
-23
-4% -$7.92K 0.07% 162
2018
Q2 		$156K Sell
538
-3
-0.6% -$843 0.07% 170
2018
Q1 		$148K Buy
+541
New +$168K 0.06% 187
2017
Q3 		– Sell
-515
Closed -$140K – 203
2017
Q2 		$140K Buy
+515
New +$136K 0.07% 172

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ferris Capital's BIIB Position: Q1 2021 in Review

Ferris Capital sold out of Biogen (BIIB) in Q1 2021, closing a stake of 858 shares — an estimated $210K sold.

Ferris Capital first reported a position in BIIB in Q2 2017 and held it in 11 quarters. The position peaked at $271K in Q1 2020. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Ferris Capital reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Ferris Capital sold 858 Biogen shares in Q1 2021, an estimated $210K.
  • Ferris Capital first reported a position in Biogen in Q2 2017 and held it in 11 quarters.
  • Ferris Capital's Biogen position peaked at $271K in Q1 2020.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Ferris Capital's 13F filing for Q1 2021, filed 14 May 2021.